Clinical Trials Directory

Trials / Unknown

UnknownNCT00465660

Resistive Exercise for Arthritic Cartilage Health (REACH)

The Effect of 6 Month High Intensity Progressive Resistance Training on Knee Articular Cartilage Morphology in Female Osteoarthritic Patients

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
60 (planned)
Sponsor
University of Sydney · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Accepted

Summary

Female subjects over the age of 40 will be recruited and randomised into a progressive resistance training (PRT) or sham-exercise group. The PRT group will train at 80% of their peak strength, using Keiser pneumatic resistance machines, and progress approximately 3% per session. Strength will be re-assessed fortnightly. Exercises will target muscles around the hip and knee. The sham-exercise group will train on the same equipment as the PRT group except hip adduction, but without added resistance or progression. Both groups will train 3 days per week for roughly 45 minutes for 6 months. It is hypothesised that high intensity PRT will decelerate the tibial and femoral cartilage degeneration in the knee affected most by OA. Primary Outcome: Articular cartilage morphology following 6 months high intensity progressive resistance training Secondary Outcomes: Muscle and fat cross-sectional area (CSA) (pre and post) Muscle strength, power, endurance, and contraction velocity (pre, 3 months, \& post) Medications (pre, 3 months, \& post) Body composition (pre, 3 months, \& post) Balance; Physical function (pre, 3 months, \& post) Questionnaires (pre, 3 months, \& post) * Habitual exercise (PASE) -WOMAC index (pain, stiffness and functional ability) * Depressive symptoms (Depression Scale) -Quality of life (SF36) * Confidence performing physical activity (Ewart) -Demographics

Conditions

Interventions

TypeNameDescription
BEHAVIORALProgressive resistance training

Timeline

Start date
2005-04-01
Completion
2009-07-01
First posted
2007-04-25
Last updated
2007-04-25

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT00465660. Inclusion in this directory is not an endorsement.